Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Stephanie Torres Boschetti, MD
Family Practice · ORLANDO, FL · NPI 1992457600
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 421 | 98 |
| Eliquis | Apixaban | 321 | 52 |
| Levothyroxine Sodium | Levothyroxine Sodium | 264 | 55 |
| Gabapentin | Gabapentin | 256 | 51 |
| Amlodipine Besylate | Amlodipine Besylate | 237 | 54 |
| Lisinopril | Lisinopril | 177 | 43 |
| Metformin Hcl | Metformin Hcl | 168 | 39 |
| Trazodone Hcl | Trazodone Hcl | 166 | 41 |
| Metoprolol Tartrate | Metoprolol Tartrate | 163 | 50 |
| Pantoprazole Sodium | Pantoprazole Sodium | 161 | 47 |
| Furosemide | Furosemide | 152 | 46 |
| Donepezil Hcl | Donepezil Hcl | 148 | 28 |
| Sertraline Hcl | Sertraline Hcl | 128 | 29 |
| Carvedilol | Carvedilol | 116 | 31 |
| Omeprazole | Omeprazole | 116 | 25 |
| Tamsulosin Hcl | Tamsulosin Hcl | 114 | 26 |
| Mirtazapine | Mirtazapine | 111 | 29 |
| Losartan Potassium | Losartan Potassium | 92 | 25 |
| Potassium Chloride | Potassium Chloride | 92 | 32 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 87 | 13 |
| Tramadol Hcl | Tramadol Hcl | 85 | 23 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 84 | 29 |
| Lorazepam | Lorazepam | 84 | 28 |
| Metoprolol Succinate | Metoprolol Succinate | 77 | 18 |
| Hydralazine Hcl | Hydralazine Hcl | 74 | 18 |
| Clopidogrel | Clopidogrel Bisulfate | 72 | 20 |
| Duloxetine Hcl | Duloxetine Hcl | 71 | 19 |
| Levetiracetam | Levetiracetam | 69 | 14 |
| Quetiapine Fumarate | Quetiapine Fumarate | 65 | 19 |
| Buspirone Hcl | Buspirone Hcl | 63 | 16 |
| Midodrine Hcl | Midodrine Hcl | 63 | 20 |
| Bumetanide | Bumetanide | 60 | 14 |
| Humalog Kwikpen U-100 | Insulin Lispro | 59 | 18 |
| Ondansetron Hcl | Ondansetron Hcl | 59 | 30 |
| Allopurinol | Allopurinol | 57 | 16 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 57 | 11 |
| Divalproex Sodium | Divalproex Sodium | 56 | 16 |
| Memantine Hcl | Memantine Hcl | 54 | 16 |
| Spironolactone | Spironolactone | 52 | 13 |
| Alprazolam | Alprazolam | 47 | 17 |
| Famotidine | Famotidine | 46 | 18 |
| Simvastatin | Simvastatin | 44 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 43 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 43 | 15 |
| Montelukast Sodium | Montelukast Sodium | 42 | suppressed |
| Nystatin | Nystatin | 40 | 15 |
| Ibuprofen | Ibuprofen | 38 | 13 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 38 | 17 |
| Jardiance | Empagliflozin | 38 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 38 | suppressed |
| Risperidone | Risperidone | 38 | suppressed |
| Latanoprost | Latanoprost | 37 | 13 |
| Escitalopram Oxalate | Escitalopram Oxalate | 35 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 34 | 15 |
| Citalopram Hbr | Citalopram Hydrobromide | 32 | suppressed |
| Novolog Flexpen | Insulin Aspart | 32 | suppressed |
| Celecoxib | Celecoxib | 31 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 31 | 17 |
| Fluticasone Propionate | Fluticasone Propionate | 31 | 13 |
| Ketoconazole | Ketoconazole | 31 | 16 |
| Methocarbamol | Methocarbamol | 31 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 30 | suppressed |
| Zenpep | Lipase/Protease/Amylase | 29 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 28 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 28 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 25 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 25 | suppressed |
| Sucralfate | Sucralfate | 25 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 25 | 19 |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 24 | suppressed |
| Trulicity | Dulaglutide | 24 | suppressed |
| Finasteride | Finasteride | 23 | suppressed |
| Januvia | Sitagliptin Phosphate | 23 | suppressed |
| Ondansetron Odt | Ondansetron | 23 | 13 |
| Oxycodone Hcl | Oxycodone Hcl | 23 | suppressed |
| Baclofen | Baclofen | 22 | 12 |
| Fentanyl | Fentanyl | 22 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 22 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 21 | 13 |
| Prednisone | Prednisone | 21 | suppressed |
| Procrit | Epoetin Alfa | 21 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 20 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 20 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 20 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 20 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 20 | suppressed |
| Otezla | Apremilast | 19 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 18 | suppressed |
| Ezetimibe | Ezetimibe | 18 | suppressed |
| Multaq | Dronedarone Hcl | 18 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 18 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 17 | 14 |
| Ammonium Lactate | Ammonium Lactate | 17 | suppressed |
| Nitroglycerin | Nitroglycerin | 17 | 14 |
| Tizanidine Hcl | Tizanidine Hcl | 17 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 16 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 16 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Glimepiride | Glimepiride | 16 | suppressed |
| Loperamide | Loperamide Hcl | 16 | suppressed |
| Vancomycin Hcl | Vancomycin/Water For Inj (Peg) | 16 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 16 | suppressed |
| Anastrozole | Anastrozole | 15 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 15 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 15 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 15 | suppressed |
| Glipizide Er | Glipizide | 15 | suppressed |
| Metronidazole | Metronidazole | 15 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 15 | 14 |
| Pravastatin Sodium | Pravastatin Sodium | 15 | suppressed |
| Pregabalin | Pregabalin | 15 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 15 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 14 | suppressed |
| Calcium Acetate | Calcium Acetate | 14 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 14 | suppressed |
| Nifedipine Er | Nifedipine | 14 | suppressed |
| Ozempic | Semaglutide | 14 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 13 | 13 |
| Pioglitazone Hcl | Pioglitazone Hcl | 13 | suppressed |
| Timolol Maleate | Timolol Maleate | 13 | suppressed |
| Torsemide | Torsemide | 13 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 12 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 12 | suppressed |
| Bicalutamide | Bicalutamide | 12 | suppressed |
| Budesonide | Budesonide | 12 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 12 | suppressed |
| Fluconazole | Fluconazole | 12 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 12 | suppressed |
| Levofloxacin | Levofloxacin | 12 | 11 |
| Memantine Hcl Er | Memantine Hcl | 12 | suppressed |
| Myrbetriq | Mirabegron | 12 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 12 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 12 | suppressed |
| Clonazepam | Clonazepam | 11 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 11 | suppressed |
| Nystop | Nystatin | 11 | 11 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 11 | suppressed |
| Valsartan | Valsartan | 11 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error